Genentech AMD Research Fellowships

As many as 11 million people in the United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050. The impact of age-related macular degeneration on the global aging population is enormous as people are deprived of their economic livelihoods and independence.

Established in 2011, the Genentech Age-related Macular Degeneration (AMD) Research Fellowships support two grants:

  • basic research in the understanding of AMD and
  • translational AMD research focusing on therapeutics (not yet in clinical trials)

Two fellowships of $40,000 each will be awarded (one for basic research and one for translational); awarded funds are dependent on the budget submitted.

The Genentech AMD Research Fellowship will not be accepting applications after 2020.

2020 Genentech AMD Research Fellowship recipients

Genentech AMD Research Fellowship (Basic)
Yi-Rong Peng, PhD
Molecular and evolutionary underpinnings of foveal formation.

Genentech AMD Research Fellowship (Translational)
Kevin James McHugh, PhD
Controlled-release ranibizumab for wet age-related macular degeneration.

 ARVO Foundation Logo